03333 231 580
Contact us
Jeff Elway
Partner
Corporate
Jeff is an experienced corporate finance and corporate M&A lawyer with over 37 years’ experience.
He has a broad practice which covers equity capital markets, mergers and acquisitions (both public companies, subject to the City Code on Takeovers and Mergers), and private equity.
Jeff has developed industry expertise in the broadband network build, natural resources, life sciences and pubs and bars sectors.
Jeff works primarily in our London office but also collaborates closely with colleagues in our other offices.
Work highlights
MERGER
Acted for Zzoomm Group Limited, the network builder and operator of full fibre broadband networks, on its merger with FullFibre, a wholesale full fibre network provider along with its in-house ISP retail company, BeFibre.
ACQUISITION
Acted for Zeus Capital Limited, as financial adviser to MIH East Holdings, Limited, a wholly-owned subsidiary of Miami International Holdings, Inc., on its recommended cash takeover offer for The International Stock Exchange Group Limited (TISE), valuing the entire issued and to be issued share capital of TISE at approx. £70.4 million, and the cash confirmation statements given by Zeus Capital Limited in respect of the takeover offer.
EQUITY CAPITAL MARKETS
Acted for OAK Securities (a trading name of Merlin Partners LLP) on the Placing and WRAP Retail Offer, raising £7.35 million for AIM-listed Oxford BioDynamics plc (a biotechnology company).
SALE
Acted for the shareholders of N-Able Holdings Ltd, a group providing a range of property related consultancy and design services focused on improving the environment, on its sale to RSK Group, a leading integrated environmental, engineering and technical services business, providing end-to-end services.
CO-INVESTMENT
Acted for Edmond de Rothschild Equity Strategies IV SLP (ERES IV fund) on its equity co-investment into Aegros Bidco, in relation to its recommended cash takeover offer (with share alternative) for AIM-listed, Alliance Pharma plc, valuing Alliance Pharma plc at £349.7 million.
FUNDRAISING
Acted for Dowgate Capital Limited and SPARK Advisory Partners on the placing of convertible loan notes to raise £1.92 million for AIM-listed, Belluscura plc, a leading medical device developer.
Recent articles
Insights
Listed shell companies whose shares were mapped into the ‘Equity shares (shell companies)’ listing category at the end of July 2024, will have been receiving letters in recent months from the FCA’s Primary Markets Monitoring Team.
11/06/2025
Announcements
DMH Stallard has announced a Partner appointment in their London corporate team. Jeff Elway brings extensive expertise in equity capital markets, mergers and acquisitions, and equity investment into private companies.
03/06/2025
Insights
DMH Stallard LLP has advised Allenby Capital Limited on its role as Aquis Corporate Adviser to Reveille Resources PLC
08/07/2026
Insights
DMH Stallard advises Carbon Responsible Limited on the sale to sustainability solutions provider Simply Sustainable.
25/06/2026